Wednesday, February 28, 2018

Why Oppenheimer Global fund is focusing on biotech as rates rise

NEW YORK (Reuters) - The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.


from Reuters: Top News http://ift.tt/2CMeoDl
at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Reseña de ‘Agatha en todas partes’: hechizos que no encantan

By Mike Hale from NYT En español https://ift.tt/uMoOkIz